Mandy Wan, Rukshana Shroff, Gordana Atanackovic, Detlef Böckenhauer, Susana Carvajal Arjona, Maria Cavaller-Bellaubi, Gunter F Egger, Olivia Boyer, Jerome Harambat, Tim Friede, Susie Gear, Oliver Gross, Frank Holtkamp, Laura H Mariani, Jennifer McKenzie, Louise Oni, Kelly Plueschke, Sabine Scherer, Svenja Seide, Marvin Sinsakul, Saskia N de Wildt, Giovanni Montini, Nicholas J A Webb, Julie R Ingelfinger, Gilles Vassal, Franz Schaefer
{"title":"A roadmap for therapeutic innovation in paediatric chronic kidney disease.","authors":"Mandy Wan, Rukshana Shroff, Gordana Atanackovic, Detlef Böckenhauer, Susana Carvajal Arjona, Maria Cavaller-Bellaubi, Gunter F Egger, Olivia Boyer, Jerome Harambat, Tim Friede, Susie Gear, Oliver Gross, Frank Holtkamp, Laura H Mariani, Jennifer McKenzie, Louise Oni, Kelly Plueschke, Sabine Scherer, Svenja Seide, Marvin Sinsakul, Saskia N de Wildt, Giovanni Montini, Nicholas J A Webb, Julie R Ingelfinger, Gilles Vassal, Franz Schaefer","doi":"10.1038/s41581-026-01148-z","DOIUrl":"https://doi.org/10.1038/s41581-026-01148-z","url":null,"abstract":"<p><p>Paediatric chronic kidney disease (CKD) is a progressive and life-altering condition that is associated with substantial comorbidities, reduced life expectancy and considerable burdens on children, families and health care systems. Despite advances in supportive medical management, therapeutic development in paediatric CKD remains sparse. Breakthroughs in the treatment of adult CKD have further exposed the therapeutic and regulatory challenges in paediatric care, underscoring an urgent need for coordinated innovation across the discovery-to-translation continuum. In this Roadmap, which was developed through an international, multidisciplinary collaboration involving paediatric and adult nephrologists, paediatric pharmacologists, biostatisticians, experts in regulatory science and health technology assessment, industry representatives and patient advocates, we articulate the therapeutic needs of children with CKD, summarize the current landscape and delineate critical constraints in clinical trial design. We also highlight the need for surrogate end-point qualification, innovative and adaptive trial methodologies, and coordinated global efforts to accelerate therapeutic innovation and address unmet needs in this underserved population.</p>","PeriodicalId":19059,"journal":{"name":"Nature Reviews Nephrology","volume":" ","pages":""},"PeriodicalIF":46.7,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149408836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"CAR T cells and T cell engagers for desensitization in kidney transplantation.","authors":"Louisa Steines, Mario Schiffer","doi":"10.1038/s41581-026-01152-3","DOIUrl":"https://doi.org/10.1038/s41581-026-01152-3","url":null,"abstract":"","PeriodicalId":19059,"journal":{"name":"Nature Reviews Nephrology","volume":" ","pages":""},"PeriodicalIF":46.7,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149394819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jae Hyun Bae, Raymond J Kreienkamp, Mathula Muhundan, Miriam S Udler, Soo Heon Kwak
{"title":"Genomic and multi-omic insights into the heterogeneity of diabetic kidney disease.","authors":"Jae Hyun Bae, Raymond J Kreienkamp, Mathula Muhundan, Miriam S Udler, Soo Heon Kwak","doi":"10.1038/s41581-026-01144-3","DOIUrl":"https://doi.org/10.1038/s41581-026-01144-3","url":null,"abstract":"<p><p>Diabetic kidney disease (DKD) is a leading cause of kidney failure and excess morbidity and mortality. Once regarded as a uniform microvascular complication of chronic hyperglycaemia, DKD is now recognized as a biologically and clinically heterogeneous condition. Not all chronic kidney disease in individuals with diabetes can be attributed to diabetes, and distinguishing DKD from non-diabetic kidney disease (non-DKD) is essential for appropriate management. Multiple interacting pathways, including hyperglycaemia, haemodynamic stress, dyslipidaemia, obesity, inflammation and ancestry-specific genetic risk, drive diverse patterns of kidney injury and clinical trajectories. Conventional classification based on glomerular filtration rate or albuminuria alone fails to capture this complexity. Emerging multi-omics approaches are reshaping our understanding of DKD by identifying genomic, epigenomic, proteomic and metabolomic signatures that stratify risk, elucidate mechanisms and inform therapeutic response. Integration of these molecular layers with polygenic scores, data-driven clustering and single-cell kidney atlases is beginning to define disease endotypes and guide precision-medicine strategies. Large-scale collaborative efforts that combine deep phenotyping, biobanking and advanced analytics are accelerating the translation of molecular heterogeneity into actionable biomarkers and therapeutic targets. Despite ongoing challenges - including the need for validation, equitable representation and clinical implementation - omics-driven precision approaches offer the potential to transform DKD management by reducing residual risk and enabling more effective, precision interventions.</p>","PeriodicalId":19059,"journal":{"name":"Nature Reviews Nephrology","volume":" ","pages":""},"PeriodicalIF":46.7,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149379772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mari Karoliina H Winkler, Stephen R Ash, Katherine A Barraclough, Christian Bluechel, Nicholas Ferrell, William Fissell, Benjamin S Freedman, Karin G F Gerritsen, Hatim A Hassan, Dirk M Hentschel, Jamie Hestekin, Alex Hughes, Dean G Johnson, Mira Krendel, Zhongwei Li, Jayme E Locke, Nuria Montserrat, Ryuichi Nishinakamura, Alexa Plisiewicz, Buddy D Ratner, Glenda V Roberts, Shuvo Roy, Tammy L Sirich, Arohan R Subramanya, Haimanot Wasse, Scott Wiener, Fokko Wieringa, Kayla Wolf, Jonathan Himmelfarb
{"title":"An integrative roadmap for a new era of kidney replacement therapies.","authors":"Mari Karoliina H Winkler, Stephen R Ash, Katherine A Barraclough, Christian Bluechel, Nicholas Ferrell, William Fissell, Benjamin S Freedman, Karin G F Gerritsen, Hatim A Hassan, Dirk M Hentschel, Jamie Hestekin, Alex Hughes, Dean G Johnson, Mira Krendel, Zhongwei Li, Jayme E Locke, Nuria Montserrat, Ryuichi Nishinakamura, Alexa Plisiewicz, Buddy D Ratner, Glenda V Roberts, Shuvo Roy, Tammy L Sirich, Arohan R Subramanya, Haimanot Wasse, Scott Wiener, Fokko Wieringa, Kayla Wolf, Jonathan Himmelfarb","doi":"10.1038/s41581-026-01146-1","DOIUrl":"https://doi.org/10.1038/s41581-026-01146-1","url":null,"abstract":"<p><p>Innovation in kidney replacement is entering a transformative era. Although precision medicine has driven major breakthroughs in disease-specific therapies, progress in translating next-generation kidney replacement strategies into practice has lagged. This updated Roadmap highlights a shift toward bold, integrative approaches that merge engineering, biology and patient-centred design. Emerging directions include reimagining filtration and tubular function through biomimetic membranes, cellular systems and organ-on-chip technologies, and simultaneously exploring microbiome modulation and sorbent-based strategies to reduce the uraemic toxin burden. Beyond improving survival, new solutions are being shaped by priorities of mobility, sustainability and quality of life, pointing toward wearable and implantable systems that move care beyond the clinic. Biologic frontiers such as xenotransplantation and stem cell regeneration are opening pathways to potentially curative therapies, although challenges in safety, equity and scalability remain. Central to these efforts is the need to embed patient perspectives and ensure that innovations align with lived experiences. This integrative approach calls for renewed investment, regulatory clarity and cross-sector collaboration to accelerate translation of advances into equitable therapies redefining the future of kidney health.</p>","PeriodicalId":19059,"journal":{"name":"Nature Reviews Nephrology","volume":" ","pages":""},"PeriodicalIF":46.7,"publicationDate":"2026-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149371280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Gerd Klinkmann, Steffen Mitzner, Jörg Vienken, Daniel A Reuter, Jens-Christian Schewe, Kristina Boss, Mitchell H Rosner, Claudio Ronco
{"title":"Human serum albumin abundance, function and removal in chronic kidney disease.","authors":"Gerd Klinkmann, Steffen Mitzner, Jörg Vienken, Daniel A Reuter, Jens-Christian Schewe, Kristina Boss, Mitchell H Rosner, Claudio Ronco","doi":"10.1038/s41581-026-01143-4","DOIUrl":"https://doi.org/10.1038/s41581-026-01143-4","url":null,"abstract":"<p><p>Human serum albumin, the most abundant protein in human plasma, exerts a multitude of physiological functions that extend beyond its canonical roles in oncotic pressure and solute transport. It acts as a dynamic interface in redox regulation, toxin clearance, immune modulation and pharmacokinetics. In chronic kidney disease, dialysis and transplantation, albumin has diagnostic and therapeutic relevance far surpassing that of a nutritional marker. Emerging insights into the structure-function relationships of albumin, including its binding dynamics, redox isoforms and post-translational modifications, challenge the current paradigm of albumin in chronic kidney disease, which focuses on preserving quantity, and suggest that a shift towards restoring quality might have clinical benefits. Here, we propose two new conceptual frameworks, the 'albumin paradox', which reconsiders albumin removal during dialysis as a potentially therapeutic mechanism, and the 'inflammation-mitigation hypothesis', which positions albumin functionality as a target in extracorporeal immune modulation. Integrating biophysical, pathophysiological and clinical perspectives, we aim to reframe albumin from a merely passive bystander and laboratory parameter to a modifiable determinant of systemic health and disease.</p>","PeriodicalId":19059,"journal":{"name":"Nature Reviews Nephrology","volume":" ","pages":""},"PeriodicalIF":46.7,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149343038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Primary cilium-mediated mechanisms of cyst formation in polycystic kidney disease.","authors":"Feng Qian, Saikat Mukhopadhyay","doi":"10.1038/s41581-026-01139-0","DOIUrl":"10.1038/s41581-026-01139-0","url":null,"abstract":"<p><p>Autosomal-dominant polycystic kidney disease (ADPKD) is characterized by progressive renal cyst formation leading to kidney failure. Mutations in PKD1 or PKD2, encoding polycystins 1 and 2, underlie most cases of ADPKD. Tolvaptan remains the only approved therapy but has limited efficacy and tolerability, underscoring the need for a deeper mechanistic understanding of disease pathogenesis. Polycystins function as cation channels in the primary cilium - a sensory organelle implicated in renal epithelial development and homeostasis. Pioneering genetic studies have established that cilia loss derepresses a cilia-dependent cyst activation programme, revealing the cilium as an active signalling compartment that restrains cystogenesis triggered by polycystin dysfunction. Structural and ciliary trafficking studies have illuminated how cilia-dependent signals drive cystogenesis in development and adult contexts, whereas ciliary length regulation offers a tractable entry point for identifying ciliary effectors. Extraciliary transcriptional and post-transcriptional pathways cooperate with ciliary signalling to modulate disease progression, often through components that serve distinct compartmental functions. Notably, both ciliary and transcriptional effectors converge on mitochondrial metabolism as a critical checkpoint, revealing an integrated cilium-metabolism axis whose disruption facilitates cystogenesis. Together, this integrated structural, functional and regulatory framework for cilia-regulated ADPKD pathogenesis points towards ciliary trafficking machinery and metabolic checkpoints as actionable therapeutic targets.</p>","PeriodicalId":19059,"journal":{"name":"Nature Reviews Nephrology","volume":" ","pages":""},"PeriodicalIF":46.7,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149323207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Rethinking the concept of 'no direct benefit' in clinical research.","authors":"Robert Kalyesubula, Grace Kansiime","doi":"10.1038/s41581-026-01150-5","DOIUrl":"https://doi.org/10.1038/s41581-026-01150-5","url":null,"abstract":"","PeriodicalId":19059,"journal":{"name":"Nature Reviews Nephrology","volume":" ","pages":""},"PeriodicalIF":46.7,"publicationDate":"2026-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149287684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The renal inner medulla serves as a protective niche for MRSA.","authors":"Ellen F Carney","doi":"10.1038/s41581-026-01149-y","DOIUrl":"https://doi.org/10.1038/s41581-026-01149-y","url":null,"abstract":"","PeriodicalId":19059,"journal":{"name":"Nature Reviews Nephrology","volume":" ","pages":""},"PeriodicalIF":46.7,"publicationDate":"2026-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149287749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Deconfounding kidney function genomics from filtration-marker biology.","authors":"Cristian Pattaro, June Fabian","doi":"10.1038/s41581-026-01145-2","DOIUrl":"https://doi.org/10.1038/s41581-026-01145-2","url":null,"abstract":"","PeriodicalId":19059,"journal":{"name":"Nature Reviews Nephrology","volume":" ","pages":""},"PeriodicalIF":46.7,"publicationDate":"2026-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149245599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}